[1]
Millard, J. et al. 2020. The Effect of a Clinical Pathway on Reducing the Rate of Healthcare-Onset Clostridioides difficile. Kansas Journal of Medicine. 13, 1 (Oct. 2020), 260–264. DOI:https://doi.org/10.17161/kjm.vol13.14762.